在多发性骨髓瘤中采用细胞疗法
David Kegyes1, Bogdan Borlea1, Marc Damian2
1Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research - Department of Hematology, Iuliu Hațieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Best practice & research. Clinical haematology
|September 7, 2025
概括
化学抗原受体 (CAR) T细胞和NK细胞疗法在治疗血细胞髓瘤方面表现有前途. 这些先进的免疫疗法越来越有效,甚至在早期的治疗阶段和作为干细胞移植的替代品.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 血细胞髓瘤是一种骨髓癌,涉及到异常的血细胞生长.
- 随着新药的批准,治疗选择不断进步.
- 化学抗原受体 (CAR) 疗法代表了免疫疗法的重大进步.
研究的目的:
- 审查CAR T细胞和NK细胞治疗血细胞髓瘤的历史和最近的进展.
- 突出CAR疗法在骨髓瘤治疗范式中的不断变化的作用.
主要方法:
- 关于CAR T细胞和NK细胞治疗进展的文献综述.
- 对早期和复发性/耐药性等离子体细胞髓瘤治疗当前研究的分析.
主要成果:
- 在复发性或耐火性多发性骨髓瘤中,CAR疗法已经证明是成功的.
- 有证据表明,CAR疗法在早期治疗线上是有效的,有可能取代自身干细胞移植.
- 目前正在进行的研究重点是将CAR疗法扩展到固体瘤,并提高安全性和疗效.
结论:
- 卡尔T细胞和NK细胞疗法正在快速发展,是血细胞髓瘤的高效治疗方法.
- 这些免疫疗法为多发性骨髓瘤患者提供了新的希望和替代策略.
相关概念视频
Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Bone Marrow Sampling and Transplants
910
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
910
Differentiation of Common Myeloid Progenitor Cells
3.9K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.9K
Stem Cell Therapy for Tissue Regeneration
4.6K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.6K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K


